Yu Wang
Chief Tech/Sci/R&D Officer at Genfleet Therapeutics (Shanghai), Inc.
Network origin in Yu Wang first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Genfleet Therapeutics (Shanghai), Inc.
 Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Yu Wang via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Miscellaneous Manufacturing | Director/Board Member | |
| AKESO, INC. | Pharmaceuticals: Major | Director/Board Member | |
| SHENZHEN YHLO BIOTECH CO., LTD. | Medical Specialties | Director/Board Member | |
| Hengyang Normal University | College/University | Undergraduate Degree | |
| Hunan Normal University | College/University | Graduate Degree | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree | |
Aoran Biotechnology (Shanghai) Co. Ltd.
 Aoran Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Aoran Biotechnology (Shanghai) Co. Ltd. is a biotechnology company based in Shanghai, China. Aoran Biotechnology specializes in molecular diagnostics. The Chinese company was founded in 2015 and the CEO is Chang Yu Jia. | Miscellaneous Commercial Services | Director/Board Member | |
| ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED | Medical Specialties | Director/Board Member | |
Shanghai Panlin Asset Management Co. Ltd.
 Shanghai Panlin Asset Management Co. Ltd. Investment ManagersFinance Shanghai Panlin Asset Management Co. Ltd. is a Private Equity and Venture Capital firm headquartered in Shanghai, China. The firm was established in 2010 founded by Yu Hui Li. | Investment Managers | Private Equity Investor | |
| GEMPHARMATECH CO., LTD. | Biotechnology | Director/Board Member | |
| Yale University | College/University | Doctorate Degree | |
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
 Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. Medical SpecialtiesHealth Technology Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. is a private company that manufactures medical equipment. The company is based in Wuxi, China. The Chinese company was founded in 1999. The CEO is Qing Song Sheng. | Medical Specialties | Director/Board Member | |
| JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD. | Containers/Packaging | Director/Board Member | |
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
 Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020. | Pharmaceuticals: Major | Director/Board Member |
Statistics
International
| China | 13 |
| Cayman Islands | 2 |
| United States | 2 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 5 |
| Producer Manufacturing | 2 |
| Commercial Services | 2 |
| Finance | 2 |
Operational
| Director/Board Member | 19 |
| Founder | 2 |
| Doctorate Degree | 2 |
| Chairman | 1 |
| Chief Executive Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Yi Zhou | 8 |
| Dan Liu | 6 |
| Qiang Lü | 2 |
| Ai Min Tang | 2 |
| Jiong Lan | 1 |
| Gao Guang Song | 1 |
| Hui Wang | 1 |
| Bin Li | 1 |
| Hai Ge Shen | 1 |
| Wei Zhang | 1 |
| Yu Fa Wei | 1 |
- Stock Market
- Insiders
- Yu Wang
- Company connections
